Bethkis®(tobramcyin) – First-time generic and authorized brand alternative
September 16, 2020 - Teva launched an AB-rated generic version and Prasco launched an authorized brand alternative of Chiesi’s Bethkis (tobramycin) inhalation solution 300 mg/4 mL.
Download PDF
